Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PANW William Blair Reiterates Outperform On Palo Alto Networks Following Earnings Results http://www.smarteranalyst.com/2014/11/26/william-blair-reiterates-outperform-on-palo-alto-networks-following-earnings-results/
$CYBR Despite Its Downgrade, William Blair Remains Long-Term Positive On CyberArk's Fundamentals http://www.smarteranalyst.com/2014/11/26/despite-its-downgrade-william-blair-remains-long-term-positive-on-cyberarks-fundamentals/
$WDAY Workday’s Long-Term Fundamentals Are As Healthy As Ever, Says William Blair http://www.smarteranalyst.com/2014/11/26/workdays-long-term-fundamentals-are-as-healthy-as-ever-says-william-blair/
$WDAY Workday’s Long-Term Fundamentals Are As Healthy As Ever, Says William Blair http://www.smarteranalyst.com/2014/11/26/workdays-long-term-fundamentals-are-as-healthy-as-ever-says-william-blair/
$AEZS UPDATE: MLV Cuts Aeterna Zentaris Price Target; Remains ‘Buyers’ Following Recent Share Declines http://www.smarteranalyst.com/2014/11/26/update-mlv-cuts-aeterna-zentaris-price-target-remains-buyers-following-recent-share-declines/
$AEZS UPDATE: MLV Cuts Aeterna Zentaris Price Target; Remains ‘Buyers’ Following Recent Share Declines http://www.smarteranalyst.com/2014/11/26/update-mlv-cuts-aeterna-zentaris-price-target-remains-buyers-following-recent-share-declines/
$BRCD BMO Maintains Market Perform On Brocade Communications, Raises PT To $12.50 http://www.smarteranalyst.com/2014/11/26/bmo-maintains-market-perform-on-brocade-communications-raises-pt-to-12-50/
$BDSI Biodelivery: We Remain On The Sidelines Pending A Few More Weeks Of Bunavail Prescriptions, Say Roth Capital http://www.smarteranalyst.com/2014/11/26/biodelivery-we-remain-on-the-sidelines-pending-a-few-more-weeks-of-bunavail-prescriptions-say-roth-capital/
$ONCS Maxim Maintains Buy On OncoSec Medical Following UCSF Medical Collaboration http://www.smarteranalyst.com/2014/11/26/maxim-maintains-buy-on-oncosec-medical-following-ucsf-medical-collaboration/
$ONCS Maxim Maintains Buy On OncoSec Medical Following UCSF Medical Collaboration http://www.smarteranalyst.com/2014/11/26/maxim-maintains-buy-on-oncosec-medical-following-ucsf-medical-collaboration/
$CIMT $DDD Roth Capital Cuts Cimatron Price Target Following 3D Systems' Acquisition http://www.smarteranalyst.com/2014/11/26/roth-capital-cuts-cimatron-price-target-following-3d-systems-acquisition/
$CIMT $DDD Roth Capital Cuts Cimatron Price Target Following 3D Systems' Acquisition http://www.smarteranalyst.com/2014/11/26/roth-capital-cuts-cimatron-price-target-following-3d-systems-acquisition/
$RNA $BMRN Roth Capital Turns Off Lights On Prosensa Following BioMarin’s Acquisition http://www.smarteranalyst.com/2014/11/25/roth-capital-turns-off-lights-on-prosensa-following-biomarins-acquisition/
$RNA $BMRN Roth Capital Turns Off Lights On Prosensa Following BioMarin’s Acquisition http://www.smarteranalyst.com/2014/11/25/roth-capital-turns-off-lights-on-prosensa-following-biomarins-acquisition/
$TSL Roth Capital Remains Positive On Trina Solar While Sentiment In The Stock May Be Challenged http://www.smarteranalyst.com/2014/11/25/roth-capital-remains-positive-on-trina-solar-while-sentiment-in-the-stock-may-be-challenged/
$ONCS H.C. Wainwright Maintains Buy On OncoSec Following New Collaboration With The University Of California http://www.smarteranalyst.com/2014/11/25/h-c-wainwright-maintains-buy-on-oncosec-following-new-collaboration-withthe-university-of-california/
$ONCS H.C. Wainwright Maintains Buy On OncoSec Following New Collaboration With The University Of California http://www.smarteranalyst.com/2014/11/25/h-c-wainwright-maintains-buy-on-oncosec-following-new-collaboration-withthe-university-of-california/
$SRPT Sarepta: Is Biomarin Really A Big Threat With An Inferior Drug? Roth Capital Comments http://www.smarteranalyst.com/2014/11/25/sarepta-is-biomarin-really-a-big-threat-with-an-inferior-drug-roth-capital-comments/
$WDAY Oppenheimer Sees Any Pull-Backs In Workday As An Opportunity To Add Shares http://www.smarteranalyst.com/2014/11/25/oppenheimer-sees-any-pull-backs-in-workday-as-an-opportunity-to-add-shares/
$WDAY Oppenheimer Sees Any Pull-Backs In Workday As An Opportunity To Add Shares http://www.smarteranalyst.com/2014/11/25/oppenheimer-sees-any-pull-backs-in-workday-as-an-opportunity-to-add-shares/
$BRCD Oppenheimer Reiterates Perform On Brocade Communications Following Fiscal Fourth Quarter Results http://www.smarteranalyst.com/2014/11/25/oppenheimer-reiterates-perform-on-brocade-communications-following-fiscal-fourth-quarter-results/
$BRCD Oppenheimer Reiterates Perform On Brocade Communications Following Fiscal Fourth Quarter Results http://www.smarteranalyst.com/2014/11/25/oppenheimer-reiterates-perform-on-brocade-communications-following-fiscal-fourth-quarter-results/
$NLNK $MRK Cantor Raises Newlink Genetics Price Target Following New Deal With Merck For Ebola Candidate http://www.smarteranalyst.com/2014/11/25/cantor-raises-newlink-genetics-price-target-following-new-deal-with-merck-for-ebola-vaccine-candidate/
$NLNK $MRK Cantor Raises Newlink Genetics Price Target Following New Deal With Merck For Ebola Candidate http://www.smarteranalyst.com/2014/11/25/cantor-raises-newlink-genetics-price-target-following-new-deal-with-merck-for-ebola-vaccine-candidate/
$PANW Palo Alto Remains A Unique Disruptor In The Network Security Market, Says Oppenheimer http://www.smarteranalyst.com/2014/11/25/palo-alto-remains-a-unique-disruptor-in-the-network-security-market-says-oppenheimer/
$PANW Palo Alto Remains A Unique Disruptor In The Network Security Market, Says Oppenheimer http://www.smarteranalyst.com/2014/11/25/palo-alto-remains-a-unique-disruptor-in-the-network-security-market-says-oppenheimer/
$WDAY Cantor Maintains Buy On Workday Following 3Q:FY15 Results http://www.smarteranalyst.com/2014/11/25/cantor-maintains-buy-on-workday-following-3qfy15-results/
$WDAY Cantor Maintains Buy On Workday Following 3Q:FY15 Results http://www.smarteranalyst.com/2014/11/25/cantor-maintains-buy-on-workday-following-3qfy15-results/
$OUTR Wedbush Reiterates Outperform On Outerwall Following Broad Prices Increases http://www.smarteranalyst.com/2014/11/25/wedbush-reiterates-outperform-on-outerwall-following-broad-prices-increases/
Wedbush Remains Neutral On Intel, But Raises Price Target Following Analyst Day http://www.smarteranalyst.com/2014/11/24/wedbush-remains-neutral-on-intel-but-raises-price-target-following-analyst-day/
$INTC Wedbush Remains Neutral On Intel, But Raises Price Target Following Analyst Day http://www.smarteranalyst.com/2014/11/24/wedbush-remains-neutral-on-intel-but-raises-price-target-following-analyst-day/
$SPLK Wedbush Raises Splunk Price Target On The Back Of Higher Estimates http://www.smarteranalyst.com/2014/11/24/wedbush-raises-splunk-price-target-on-the-back-of-higher-estimates/
$SPLK Wedbush Raises Splunk Price Target On The Back Of Higher Estimates http://www.smarteranalyst.com/2014/11/24/wedbush-raises-splunk-price-target-on-the-back-of-higher-estimates/
$DWCH Datawatch: The Large Top-Line Miss Will Keep Shares Range-Bound, Says William Blair http://www.smarteranalyst.com/2014/11/24/datawatch-te-large-top-line-miss-will-keep-shares-range-bound-says-william-blair/
$NBS Group Remains Positive On Neostem After Reviewing Interviews From AHA Meeting http://www.smarteranalyst.com/2014/11/24/maxim-group-maintains-buy-on-neostem-following-american-heart-association-meeting/
$NBS Group Remains Positive On Neostem After Reviewing Interviews From AHA Meeting http://www.smarteranalyst.com/2014/11/24/maxim-group-maintains-buy-on-neostem-following-american-heart-association-meeting/
$RGLS Deutsche Bank Sees Short And Long Term Upside In Regulus’ Pipeline Assets http://www.smarteranalyst.com/2014/11/24/deutsche-bank-sees-short-and-long-term-upside-in-regulus-pipeline-assets/
$SHLX Sees Plenty Of Organic Growth In Shell Midstream, Says UBS; Initiates Buy http://www.smarteranalyst.com/2014/11/24/sees-plenty-of-organic-growth-in-shell-midstream-says-ubs-initiates-buy/
$FSLR Axiom Maintains Sell On First Solar Shares; Sees 40% Downside http://www.smarteranalyst.com/2014/11/24/axiom-maintains-sell-on-first-solar-shares-sees-40-downside/
$HPQ Deutsche Bank Raises Hewlett-Packard Price Target On Profitability Improvements Expectations http://www.smarteranalyst.com/2014/11/24/deutsche-bank-raises-hewlett-packard-price-target-on-profitability-improvements-expectations/